Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Simcere receives buyout offer from founder, ex CEO
Yahoo/AP
Monday, March 11, 2013 - 10:58am
tags:
Simcere, M&A
The Medicines Co's.Cangrelor show favorable results in ischemic events
Yahoo/Fly on the Wall
Monday, March 11, 2013 - 10:56am
tags:
Cangrelor, Medicines Company
AbbVie seeks to stop EU agency releasing drug data
Reuters
Monday, March 11, 2013 - 10:46am
tags:
AbbVie, drug data, EMA, Europe
Is Opko Still A Buy As Frost Continues To Purchase Shares?
Seeking Alpha
Monday, March 11, 2013 - 10:44am
tags:
OPKO Health, Bristol-Myers Squibb, RXi Pharmaceuticals
Discovery Labs Earnings: An Early Look
Motley Fool
Monday, March 11, 2013 - 10:43am
tags:
earnings, Discovery Labs
J&J Faces Second Trial Over Recalled Hip After Loss
Bloomberg
Monday, March 11, 2013 - 10:40am
tags:
recalls, JNJ, hip implants
Study shows superiority of pitavastatin on LDL-C reduction in HIV adults with dyslipidemia
Pharmabiz
Sunday, March 10, 2013 - 12:08pm
tags:
dyslipidemia, Kowa, HIV, Livalo
2 Dow Darlings Boosting Market Health This Week
Wall Street Cheat Street
Sunday, March 10, 2013 - 12:05pm
tags:
Merck, Pfizer
The Best Choice in Healthcare, Period
Motley Fool
Sunday, March 10, 2013 - 12:05pm
tags:
JNJ
Serious side effects seen with failed Merck niacin drug -study
Reuters
Sunday, March 10, 2013 - 12:03pm
tags:
Merck, Tredaptive, niacin, HDL therapy, HDL cholesterol
Is This The End Of A Widely Used Heart Drug?
Forbes
Sunday, March 10, 2013 - 12:02pm
tags:
Merck, Tredaptive, niacin, HDL cholesterol, HDL therapy
China Biotech In Review: WuXi PharmaTech Reports Another Year Of Steadily Increasing Growth
Seeking Alpha
Sunday, March 10, 2013 - 11:58am
tags:
WuXi PharmaTech, Sinopharm, Fosun Pharmaceutical, EntreMed, Viva Biotech, China National Biotec Group
Geron Earnings: An Early Look
Motley Fool
Sunday, March 10, 2013 - 11:55am
tags:
Geron, earnings
Peregrine Pharmaceuticals Earnings: An Early Look
Motley Fool
Sunday, March 10, 2013 - 11:55am
tags:
Peregrine Pharmaceuticals, earnings
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, March 9, 2013 - 12:45pm
tags:
Repros Therapeutics, JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals
Catalyst Pharmaceutical And Dynavax Are Buys Now
Seeking Alpha
Saturday, March 9, 2013 - 12:44pm
tags:
Catalyst Pharmaceutical Partners, Dynavax
Teva Enrolls Patients in MS Study - Analyst Blog
NASDAQ
Saturday, March 9, 2013 - 12:43pm
tags:
laquinimod, Teva Pharmaceuticals, multiple sclerosis, MS
Actavis Confirms Generic Version Of Novartis' Dementia Therapy
istockanalyst
Saturday, March 9, 2013 - 12:37pm
tags:
Actavis, Novartis, Exelon Patch, Alzheimer's disease, Parkinson's Disease
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 9, 2013 - 12:34pm
tags:
Corcept Therapeutics, Vivus, Cempra
Hip Defect Could Cost Johnson & Johnson Billions
Wall Street Cheat Street
Saturday, March 9, 2013 - 12:33pm
tags:
hip implants, hip recall, recall, JNJ, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.